SLQT Earnings Date: Nov 4, 2026 (Estimated) — SelectQuote, Inc.
NYSE · Financials · Insurance Brokers
Updated
When is SLQT's next earnings date?
SelectQuote, Inc. (SLQT) is expected to report Q1 2027 earnings on Wednesday, November 4, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.30 on revenue of $277.9M.
How did SLQT do in its last earnings report?
In its most recent report on Aug 25, 2026 (Q4 2026), SelectQuote, Inc. posted EPS of -$0.19 versus the -$0.17 estimate, a miss of 35.7%. Revenue was $321.7M against a $353.4M estimate. The stock's 1-day post-earnings move was -29.3%.
How much does SLQT stock move after earnings?
SLQT beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 31.1% (up or down) in the day after earnings.
About SelectQuote, Inc.
SelectQuote, Inc. operates as a tech-driven, direct-to-consumer marketplace, offering a wide spectrum of insurance products to individuals throughout the United States. These policies are underwritten by a variety of insurance carriers. The company structures its operations across three core divisions: Senior, Life, and Auto & Home. Within its Senior segment, SelectQuote provides access to a comprehensive suite of health policies, including Medicare Advantage, Medicare Supplement, and Medicare Part D plans. This segment also features ancillary coverages such as prescription drug plans, dental, vision, and hearing benefits. The Life division concentrates on term life insurance offerings, while the Auto & Home segment delivers personal automobile, homeowners', and general casualty insurance solutions. Established in 1999, SelectQuote, Inc. is headquartered in Overland Park, Kansas.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-25 | Q4 2026 | -0.17 | -0.19 | -35.71% | $321.7M | ❌ Miss | -29.34% | -27.84% | -44.21% |
| 2026-05-05 | Q3 2026 | 0.01 | 0.15 | +1400.00% | $430.9M | ✅ Beat | +52.43% | +27.84% | +15.97% |
| 2026-02-05 | Q2 2026 | 0.24 | 0.26 | +8.33% | $537.1M | ✅ Beat | -28.97% | -39.31% | -47.92% |
| 2025-11-06 | Q1 2026 | -0.30 | -0.26 | +13.33% | $328.8M | ✅ Beat | -21.13% | -23.94% | -34.74% |
| 2025-08-21 | Q4 2025 | -0.15 | -0.02 | +86.67% | $345.1M | ✅ Beat | +41.53% | +31.69% | +12.02% |
| 2025-02-10 | Q2 2025 | 0.10 | 0.30 | +200.00% | $481.1M | ✅ Beat | +30.82% | +38.13% | -17.35% |
| 2024-11-04 | Q1 2025 | -0.18 | -0.26 | -44.44% | $292.3M | ❌ Miss | -0.49% | +16.67% | +41.67% |
| 2024-09-13 | Q4 2024 | -0.15 | -0.18 | -20.00% | $307.2M | ❌ Miss | -43.73% | -44.29% | -37.60% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q4 FY26 · $321.7M total
| Segment | Share | Revenue | YoY | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|---|---|---|
| Pharmacy | 59.0% | $189.8M | -9.9% | $180.0M | $185.3M | $210.6M | $218.5M |
| Service | 41.0% | $131.8M | -2.0% | $301.1M | $222.9M | $134.5M | $110.3M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.